EurekAlert! -
12 Jan 2018 07:00
(University of the Basque Country ) Current therapies for Parkinson's disease are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed. As part of her PhD thesis, Catalina Requejo, documented the regenerative, neuroprotective effect of two neurotrophic factors when they are applied in a combined w...
Share this Article